Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Nailfold Latanoprostene Bunod on Capillary Blood Flow
NCT03949244Phase 4Completed
- Sponsor
- Icahn School of Medicine at Mount Sinai
- Start
- Aug 2019
- Primary completion
- Oct 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of latanoprostene bunod in primary open-angle glaucoma (POAG), sponsored by Icahn School of Medicine at Mount Sinai. Started Aug 2019; status: completed.
02
Drugs
latanoprostene bunod
03
Conditions
primary open-angle glaucoma (POAG)
Beyond the preview
Go deeper on NCT03949244.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03949244.